2013
DOI: 10.1007/s10463-013-0436-7
|View full text |Cite
|
Sign up to set email alerts
|

Bayesian nonparametric modeling for functional analysis of variance

Abstract: Analysis of variance (ANOVA) is a standard statistical modeling approach for comparing populations. The functional analysis setting envisions that mean functions are associated with the populations, customarily modeled using basis representations, and seeks to compare them. More recently, these functions have been modeled as realizations of stochastic processes. Here, we adopt this latter approach, offering several novel contributions. First, we extend the Gaussian process version to allow nonparametric specif… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 23 publications
0
4
0
Order By: Relevance
“…In this section, we discuss definitions of the biomarker functional profile, Δ. Measures of distributional change based on Bayesian nonparametric priors recently have been considered by Nguyen and Gelfand (), who describe Lr‐norm, variational and symmetrized Kullback–Leibler distances between realizations of a random probability measure in a functional ANOVA setting. Here, our objective is different, as our goals are to estimate how a biomarker changes due to treatment and relate this to the outcome T. For example, if on average a given treatment results in a decrease of a biomarker's levels, this information usually is hidden by area‐based measures such as those noted above.…”
Section: Biomarker Distributional Change Functionalsmentioning
confidence: 99%
“…In this section, we discuss definitions of the biomarker functional profile, Δ. Measures of distributional change based on Bayesian nonparametric priors recently have been considered by Nguyen and Gelfand (), who describe Lr‐norm, variational and symmetrized Kullback–Leibler distances between realizations of a random probability measure in a functional ANOVA setting. Here, our objective is different, as our goals are to estimate how a biomarker changes due to treatment and relate this to the outcome T. For example, if on average a given treatment results in a decrease of a biomarker's levels, this information usually is hidden by area‐based measures such as those noted above.…”
Section: Biomarker Distributional Change Functionalsmentioning
confidence: 99%
“…It is possible to model additive response surfaces with a GP by choosing a suitable covariance function. The first such effort can be traced to [60] and has been recently revisited by [61][62][63][64][65]. By exploiting the additive structure of response surfaces one can potentially deal with a few hundred to a few thousand input dimensions.…”
Section: Introductionmentioning
confidence: 99%
“…Another example of an exploitable response surface feature is active subspaces (AS) [66]. An AS is a low-dimensional linear manifold of the input space characterized by maximal response variation.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, GP prior has also been increasingly employed in Bayesian FDA. For instance, GP has been used as the prior for functional batch effects (Kaufman et al 2010) and as the base measure for a Dirichlet process prior (Nguyen and Gelfand 2014) in functional ANOVA. GP regression has also been used in FDA (see, e.g., Shi and Choi (2011), Shi et al (2012), and Wang and Shi (2014)), providing a nonparametric linkage between a functional predictor and a functional response.…”
Section: Introductionmentioning
confidence: 99%